702 filings
Page 5 of 36
UPLOAD
c6rztktkpods7
25 Oct 19
Letter from SEC
12:00am
SC TO-I/A
pzpz ycwog64sm
26 Sep 19
Issuer tender offer statement (amended)
4:24pm
8-K
3a3d7ha01c2xdp3l
6 Sep 19
Adhera and Allegis Pharma Announce Co-Promotion Agreement
7:30am
UPLOAD
wbqzz sc3y77yb
23 Aug 19
Letter from SEC
12:00am
SC TO-I
glufrtu eim
20 Aug 19
Issuer tender offer statement
5:01pm
8-K
sm9uuwijv4b
7 Aug 19
Entry into a Material Definitive Agreement
4:45pm
D
ow8k8 se0xbfrh3
11 Jul 19
$7M in debt, sold $3.24M, 45 investors
4:31pm
8-K
aw8yg3fypaq6wp
3 Jul 19
Entry into a Material Definitive Agreement
5:00pm
SC TO-I/A
xnn9g5x4 4pae
2 Jul 19
Issuer tender offer statement (amended)
4:18pm
UPLOAD
xc729lcyryjoclu4q
7 Jun 19
Letter from SEC
12:00am
SC TO-I/A
6eq1bh7haqdn
6 Jun 19
Issuer tender offer statement (amended)
5:01pm
SC TO-I
4iom709z9vqevxs9po
28 May 19
Issuer tender offer statement
5:26pm
S-8
eehzkf
3 May 19
Registration of securities for employees
5:06pm
8-K
zqh2e0rxl
5 Apr 19
Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
9:29am
NT 10-K
62d7rt1x5snyk6v3v
2 Apr 19
Notice of late annual filing
5:00pm